509 related articles for article (PubMed ID: 9209296)
21. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
22. Systemic diseases in patients with HTLV-1-associated uveitis.
Nakao K; Abematsu N; Sakamoto T
Br J Ophthalmol; 2018 Mar; 102(3):373-376. PubMed ID: 28689168
[TBL] [Abstract][Full Text] [Related]
23. A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.
Arisaw K; Katamine S; Kamihira S; Kurokawa K; Sawada T; Soda M; Doi H; Saito H; Shirahama S
Cancer Causes Control; 2002 Sep; 13(7):657-63. PubMed ID: 12296513
[TBL] [Abstract][Full Text] [Related]
24. [Natural history of HTLV-I infection].
Yamaguchi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):770-4. PubMed ID: 1630039
[TBL] [Abstract][Full Text] [Related]
25. Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis.
Rowan AG; Dillon R; Witkover A; Melamed A; Demontis MA; Gillet NA; Mun LJ; Bangham CRM; Cook LB; Fields PA; Taylor GP
Blood; 2020 Jun; 135(23):2023-2032. PubMed ID: 32160278
[TBL] [Abstract][Full Text] [Related]
26. Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population.
Ikeda S; Momita S; Kinoshita K; Kamihira S; Moriuchi Y; Tsukasaki K; Ito M; Kanda T; Moriuchi R; Nakamura T
Blood; 1993 Oct; 82(7):2017-24. PubMed ID: 8400254
[TBL] [Abstract][Full Text] [Related]
27. DNA diagnosis of HTLV-I.
Yamaguchi K; Matsuoka M; Takemoto S; Tamiya S; Etoh K; Takatsuki K
Intervirology; 1996; 39(3):158-64. PubMed ID: 9058168
[TBL] [Abstract][Full Text] [Related]
28. [Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases].
Gessain A
Bull Soc Pathol Exot; 2011 Aug; 104(3):167-80. PubMed ID: 21796326
[TBL] [Abstract][Full Text] [Related]
29. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.
Tsukasaki K; Tobinai K
Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371
[TBL] [Abstract][Full Text] [Related]
30. Biology and treatment of HTLV-1 associated T-cell lymphomas.
Tsukasaki K; Tobinai K
Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636
[TBL] [Abstract][Full Text] [Related]
31. Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.
Yoshida N; Chihara D
Curr Treat Options Oncol; 2015 Feb; 16(2):7. PubMed ID: 25762122
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
Hisada M; Okayama A; Shioiri S; Spiegelman DL; Stuver SO; Mueller NE
Blood; 1998 Nov; 92(10):3557-61. PubMed ID: 9808547
[TBL] [Abstract][Full Text] [Related]
33. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.
Tamiya S; Matsuoka M; Etoh K; Watanabe T; Kamihira S; Yamaguchi K; Takatsuki K
Blood; 1996 Oct; 88(8):3065-73. PubMed ID: 8874205
[TBL] [Abstract][Full Text] [Related]
34. Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).
Tajima K
Cancer Metastasis Rev; 1988 Nov; 7(3):223-41. PubMed ID: 3067901
[TBL] [Abstract][Full Text] [Related]
35. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
[TBL] [Abstract][Full Text] [Related]
36. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
[TBL] [Abstract][Full Text] [Related]
37. [Human T-cell leukemia virus type I and adult T-cell leukemia-lymphoma].
Shimoyama M
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):589-600. PubMed ID: 2181940
[TBL] [Abstract][Full Text] [Related]
38. Molecular detection of pre-ATL state among healthy HTLV-1 carriers in an endemic area of Japan.
Chen YX; Ikeda S; Mori H; Hata T; Tsukasaki K; Momita S; Yamada Y; Kamihira S; Mine M; Tomonaga M
Int J Cancer; 1995 Mar; 60(6):798-801. PubMed ID: 7896448
[TBL] [Abstract][Full Text] [Related]
39. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
[TBL] [Abstract][Full Text] [Related]
40. HTLV-I-associated leukemia/lymphoma in south Florida.
Harrington WJ; Miller GA; Kemper RR; Byrne GE; Whitcomb CC; Rabin M
J Acquir Immune Defic Syndr (1988); 1991; 4(3):284-9. PubMed ID: 1992105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
